Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4e70 | N7I | Coniferyl alcohol 9-O-methyltransferase |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4e70 | N7I | Coniferyl alcohol 9-O-methyltransferase | / | 1.000 | |
1xqc | AEJ | Estrogen receptor | / | 0.498 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.497 | |
2xke | WI2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.483 | |
4f79 | P53 | Putative phospho-beta-glucosidase | / | 0.483 | |
4xp4 | COC | Sodium-dependent dopamine transporter | / | 0.478 | |
3tam | M06 | Gag-Pol polyprotein | 2.7.7.49 | 0.477 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.476 | |
2wqo | VGK | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.475 | |
4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.473 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.472 | |
3a1l | 2CC | Cytochrome P450 | / | 0.472 | |
2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.471 | |
1df8 | BTN | Streptavidin | / | 0.470 | |
2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.470 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.470 | |
3tfj | THG | Dimethylsulfonioproprionate demethylase DmdA | 2.1.1.269 | 0.469 | |
1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.468 | |
3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.468 | |
2xkf | BX1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.467 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.467 | |
4msk | 2C8 | Tankyrase-1 | 2.4.2.30 | 0.467 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.467 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.466 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.466 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.465 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.465 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.465 | |
4bub | ADP | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--LD-lysine ligase | / | 0.465 | |
3qak | UKA | Adenosine receptor A2a | / | 0.465 | |
3t1a | 5MA | Gag-Pol polyprotein | 2.7.7.49 | 0.464 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.463 | |
4uog | YYY | Nucleoside diphosphate kinase | / | 0.463 | |
1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.462 | |
1w7k | ADP | Dihydrofolate synthase/folylpolyglutamate synthase | 6.3.2.12 | 0.462 | |
2opb | F21 | Phenylethanolamine N-methyltransferase | 2.1.1.28 | 0.462 | |
3e6o | A55 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.462 | |
5d1b | TSN | Histone deacetylase 8 | 3.5.1.98 | 0.462 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.461 | |
2jle | I15 | Reverse transcriptase/RNaseH | / | 0.460 | |
3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.460 | |
1tll | FMN | Nitric oxide synthase, brain | 1.14.13.39 | 0.459 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.459 | |
3f82 | 353 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.459 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.459 | |
4jlt | 8PR | Cytochrome P450 2B4 | 1.14.14.1 | 0.459 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.459 | |
1sjw | NGV | Nogalonic acid methyl ester cyclase | / | 0.458 | |
3g70 | A5T | Renin | 3.4.23.15 | 0.458 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.458 | |
4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.458 | |
3uza | T4G | Adenosine receptor A2a | / | 0.458 | |
2b5j | 3AC | Gag-Pol polyprotein | 2.7.7.49 | 0.457 | |
3ldg | SAH | Uncharacterized protein | / | 0.457 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.457 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.457 | |
2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.456 | |
4i9i | 1DY | Tankyrase-1 | 2.4.2.30 | 0.456 | |
1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.455 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.455 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.455 | |
3ewr | APR | Replicase polyprotein 1a | 3.4.22 | 0.455 | |
3is9 | AC7 | Gag-Pol polyprotein | 2.7.7.49 | 0.455 | |
3lla | ACP | Myosin heavy chain kinase A | 2.7.11.7 | 0.455 | |
1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.454 | |
3e7t | B14 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.454 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.454 | |
1kzu | RG1 | Light-harvesting protein B-800/850 alpha chain | / | 0.453 | |
1kzu | RG1 | Light-harvesting protein B-800/850 beta chain | / | 0.453 | |
1uxu | NAP | NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase | / | 0.453 | |
3n65 | XFJ | Nitric oxide synthase, brain | 1.14.13.39 | 0.453 | |
3ntz | 3TZ | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
4ea1 | 3RX | Dehydrosqualene synthase | / | 0.453 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.453 | |
4rw6 | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.453 | |
1srf | MTB | Streptavidin | / | 0.452 | |
3qcz | ANP | Dihydrofolate synthase/folylpolyglutamate synthase | / | 0.452 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.452 | |
4m48 | 21B | Sodium-dependent dopamine transporter | / | 0.452 | |
4mmd | 29E | Na(+):neurotransmitter symporter (Snf family) | / | 0.452 | |
1qw5 | 14W | Nitric oxide synthase, inducible | 1.14.13.39 | 0.451 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.451 | |
2won | ZZE | Gag-Pol polyprotein | 2.7.7.49 | 0.451 | |
3ar6 | 12D | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.451 | |
3tm0 | ANP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.451 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
1pr5 | TBN | Purine nucleoside phosphorylase DeoD-type | / | 0.450 | |
2f98 | NGV | Aklanonic acid methyl ester cyclase AcmA | 5.5.1.23 | 0.450 | |
2ph5 | NAD | Homospermidine synthase | / | 0.450 | |
2v57 | PRL | TetR family transcriptional regulator | / | 0.450 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.450 | |
2z7g | EH9 | Adenosine deaminase | 3.5.4.4 | 0.450 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.450 | |
3qpv | ADP | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 2.7.1.105 | 0.450 | |
4f1o | ACP | Probable serine/threonine-protein kinase roco4 | 2.7.11.1 | 0.450 | |
1qin | GIP | Lactoylglutathione lyase | 4.4.1.5 | 0.449 | |
4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.449 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.448 | |
3hbf | MYC | Flavonoid 3-O-glucosyltransferase | 2.4.1 | 0.448 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.448 | |
3rey | XAC | Adenosine receptor A2a | / | 0.448 | |
1p33 | MTX | Pteridine reductase 1 | 1.5.1.33 | 0.447 | |
1zdw | FLV | Prenyltransferase | / | 0.447 | |
2yhu | WHF | Pteridine reductase | / | 0.447 | |
3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.447 | |
4ivq | I43 | Thymidine kinase | / | 0.447 | |
2x9v | TMQ | Pteridine reductase | / | 0.446 | |
3c6u | M22 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
3n1s | 5GP | Purine nucleoside phosphoramidase | / | 0.446 | |
4bjb | P34 | Tankyrase-2 | 2.4.2.30 | 0.446 | |
4gd9 | BTN | Streptavidin | / | 0.446 | |
4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.446 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.446 | |
4mmc | 29J | Na(+):neurotransmitter symporter (Snf family) | / | 0.446 | |
5iub | CLR | Adenosine receptor A2a | / | 0.446 | |
1kyz | FER | Caffeic acid 3-O-methyltransferase | 2.1.1.68 | 0.445 | |
1w22 | NHB | Histone deacetylase 8 | 3.5.1.98 | 0.445 | |
2fjm | 073 | Tyrosine-protein phosphatase non-receptor type 1 | 3.1.3.48 | 0.445 | |
2xk4 | OL2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.445 | |
3zec | ANP | Adenosine monophosphate-protein transferase SoFic | 2.7.7.n1 | 0.445 | |
4uoh | ADP | Nucleoside diphosphate kinase | / | 0.445 | |
1o6r | R19 | Squalene--hopene cyclase | 4.2.1.129 | 0.444 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.444 | |
1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
2c92 | TP6 | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.444 | |
2hz4 | 4ST | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.444 | |
2imk | GTX | AGAP009194-PA | / | 0.444 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.444 | |
1ro6 | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.443 | |
1s2g | 3D1 | Nucleoside 2-deoxyribosyltransferase | / | 0.443 | |
2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.443 | |
3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.443 | |
3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.443 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.443 | |
4pl9 | ADP | Ethylene receptor 1 | / | 0.443 | |
4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.443 | |
1a27 | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.442 | |
2jav | 5Z5 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.442 | |
2xkd | T3M | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.442 | |
2xlr | FAD | Putative flavin-containing monooxygenase | / | 0.442 | |
3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.442 | |
3q2j | CKI | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.442 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
4h4o | 506 | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1e2j | THM | Thymidine kinase | / | 0.441 | |
1v79 | FR7 | Adenosine deaminase | 3.5.4.4 | 0.441 | |
1vzq | SHY | Prothrombin | 3.4.21.5 | 0.441 | |
1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.441 | |
2etr | Y27 | Rho-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
3tfn | 2CJ | Dehydrosqualene synthase | / | 0.441 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.441 | |
4dvi | 2IW | Tankyrase-1 | 2.4.2.30 | 0.441 | |
4fev | PP1 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.441 | |
4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.441 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.441 | |
1ly4 | COQ | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
2xtb | KRM | Adenosine kinase, putative | / | 0.440 | |
2xwe | AMF | Glucosylceramidase | 3.2.1.45 | 0.440 | |
3c34 | KAI | Glutamate receptor ionotropic, kainate 1 | / | 0.440 | |
3o9l | LPN | Renin | 3.4.23.15 | 0.440 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 |